京新藥業(002020.SZ):擬終止回購公司股份 已回購1936.42萬股將予以註銷
格隆匯 9 月 11日丨京新藥業(002020.SZ)公佈,2020年9月11日,公司召開第七屆董事會第十五次會議,審議通過了《關於終止回購公司股份的議案》,為推進公司2020年度非公開發行A股股票事項的實施,同意公司提前終止回購公司股份事項。議案還需提交公司股東大會審議通過後方可實施。
鑑於《深圳證券交易所上市公司回購股份實施細則》第二十條的規定:上市公司在回購期間不得發行股份募集資金,但依照有關規定發行優先股的除外。公司已於2020年7月14日披露《2020年非公開發行股票預案》,並於2020年7月28日披露《2020年非公開發行股票預案(修訂稿)》,為順利推進本次非公開發行股票事宜,公司董事會經與中介機構、法律顧問進行審慎研究後決定提前終止本次回購公司股份事項。
根據《深圳證券交易所股票上市規則》、《深圳證券交易所上市公司回購股份實施細則》等法律、法規及規範性文件的有關規定,本次提前終止回購股份事項還需提交公司股東大會審議通過後方可實施。
根據公司《回購部分社會公眾股方案》,公司本次已回購股份1936.4224萬股將予以註銷並減少公司註冊資本,公司股本將由7.24872億股變更為7.05507776億股,註冊資本將由7.24872億元變更7.05507776億元。公司將根據後續進展情況及時履行信息披露義務,敬請投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.